Amylyx Pharmaceuticals
AMLX
AMLX
143 hedge funds and large institutions have $141M invested in Amylyx Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 48 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
143
Holders Change
-35
Holders Change %
-19.66%
% of All Funds
2.07%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
25
Increased
56
Reduced
48
Closed
60
Calls
$20.5M
Puts
$10.6M
Net Calls
+$9.95M
Net Calls Change
+$9.39M
Top Buyers
| 1 |
Goldman Sachs
New York
|
$8.36M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
$4.26M |
| 3 |
Two Sigma Investments
New York
|
$4.07M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
$3.27M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
$2.86M |
